| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K19103580 |
| PharmacoGx | BRD-K19103580 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABHD3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ABLIM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ABRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | AC006026.1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AC006116.20 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AC007325.2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
